> The FDA has rejected a bid by Nastech Pharmaceutical to make a generic version of Novartis' Miacalcin osteoporosis nasal spray. Regulators said that they were concerned that Nastech's proposal to combine ingredients raised the possibility of triggering an immune reaction among patients. Report
> Elusys Therapeutics has garnered $11 million in an extension of its fourth round. MedImmune Ventures, joined current investors including Essex Woodlands Health Ventures, Crescendo Ventures and Invesco Private Capital. Release
> Corautus Genetics announced that the FDA has lifted its hold on its Phase IIb trial for severe angina. A partial hold will remain until Corautus Genetics resolves the remaining issues with the agency. Report
> Alexion Pharmaceuticals has acquired a plant Dow Chemical shuttered in 2004 and plans to use it to manufacture a therapy for a genetic blood disorder. Report
> JAMA has tightened rules on the financial disclosures it requires from researchers outlining any ties they may have to drug companies and device makers. The new rules were triggered by fresh revelations that researchers had failed to divulge financial ties to drug companies whose products were at the center of a study. But critics say that the new rules aren't strong enough, suggesting that authors who violate the rules should be banned from publishing. Report
> In a lopsided vote, the U.S. Senate approved a provision that would allow drug imports from Canada, but most observers doubt that the loophole will survive negotiations with the House. Report
> The stem cell therapy biotech TheraVitae has established a North American subsidiary. Report
> Diagnostics manufacturer Biosite has won FDA approval to add methadone to its Triage TOX Drug Screen. Report
> Jurors in New Jersey ended their first day of deliberations on the latest Vioxx case without rendering a verdict. Report
And Finally… A paralyzed man was able to operate a computer through the use of a sensor implanted in his brain, offering some hope to severely debilitated patients. Article